TRAMPOLINE PHARMA, INC.: Development of a Universal Next Generation T Cell Receptor Cancer Therapy: Preclinical Proof-of-Concept and Optimization

TRAMPOLINE PHARMA, INC. (Aurora, Colorado): Development of a Universal Next Generation T Cell Receptor Cancer Therapy: Preclinical Proof-of-Concept and Optimization. Its award of $398,039 is below the median of $407,048 (49th percentile). Dated 55 days ago, it serves as a historical benchmark. Score 40/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

award: $398,039 · 49th percentile of 10,712 NihBiotechGrantPulse records · 1.0x the median

Free preview: all 10 published fields of this record are shown below. Locked: 219 related CO NihBiotechGrantPulse records and the 5-column CSV export.

FieldValue
OrganizationTRAMPOLINE PHARMA, INC.
LocationAURORA, CO
ProjectDevelopment of a Universal Next Generation T Cell Receptor Cancer Therapy: Preclinical Proof-of-Concept and Optimization
Project number1R43CA310292-01
MechanismR43
InstituteNational Cancer Institute
Award$398,039
Awarded2026-09-10
Project period2026-09-10 to 2027-08-31
UEIQAE3GETX9Z88
award percentile49th of 10,712 (median $407,048, 1.0x median)
Peer records CSV (220 CO records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch TRAMPOLINE PHARMA, INC.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of CO records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock TRAMPOLINE PHARMA + all 220 CO records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL

  • Source agency: NIH RePORTER (newly awarded projects)
  • Record date: 2026-09-10
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all CO records free →

Top NihBiotechGrantPulse records (CO first): UNIVERSITY OF COLORADO DENVER · NATIONAL JEWISH HEALTH · COLORADO STATE UNIVERSITY · UNIVERSITY OF COLORADO DENVER · NATIONAL JEWISH HEALTH · Browse all by state and category →

LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: TRAMPOLINE PHARMA, INC. and 220 Colorado peers

  • Colorado NihBiotechGrantPulse records like this one: 220
  • TRAMPOLINE PHARMA, INC.'s award: 49th percentile of 10,712 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Colorado peer: $44,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more NihBiotechGrantPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

40 / 100 Lab Budget Score

  • Award of $398,039.
  • Research or center grant: supplies, instruments and services budget.

What is the NihBiotechGrantPulse record for TRAMPOLINE PHARMA, INC. in Aurora, Colorado?

TRAMPOLINE PHARMA, INC. received an NIH award of $398,039 on 2026-09-10: Development of a Universal Next Generation T Cell Receptor Cancer Therapy: Preclinical Proof-of-Concept and Optimization.

How does TRAMPOLINE PHARMA, INC. compare to other Colorado NihBiotechGrantPulse records?

Its award of $398,039 is below the median (49th percentile); smaller records often move faster and face less competition. It is 55 days old; check the official source for later updates before acting.

TRAMPOLINE PHARMA, INC. vs. top 3 peers

OrganizationLocationAmountPercentileRecord date
TRAMPOLINE PHARMA, INC.AURORA, CO398,03949th2026-09-10
COMMONSPIRIT HEALTH RESEARCH INSTITUTEENGLEWOOD, CO1,011,62987th2026-09-17
ALLANDER BIOTECHNOLOGIES, INC.AURORA, CO1,066,14888th2026-09-14
UNIVERSITY OF COLORADO DENVERAurora, CO1,170,43590th2026-09-18

Related records

NihBiotechGrantPulse: records in Colorado NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)

More Colorado public-record feeds

New Federal, Colorado, NYC & Chicago Lobbying Clients in Colorado Colorado Custom Meat Processors Pulse in Colorado Nursing Home Inspection Deficiencies by State & Severity in Colorado Federal Alcohol Permit Holder Directory in Colorado CMS HAC Reduction & Readmissions Penalties by Hospital in Colorado Excluded Health Care Business Search (OIG LEIE) in Colorado Newly Posted IRS Automatic Revocations of Tax Exemption in Colorado FEMA Hazard Mitigation Project Tracker in Colorado

How to monitor TRAMPOLINE PHARMA, INC. and peer small business sbir/sttr (r41-r44, u43-u44) records

Get new NihBiotechGrantPulse records like TRAMPOLINE PHARMA, INC. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together